Á. Cano

发表

Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

C. Tebé, P. Martín-Dávila, J. Rodríguez-Baño, 2017, Antimicrobial Agents and Chemotherapy.

Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients

E. Pérez-Nadales, L. Martínez-Martínez, J. Torre-Cisneros, 2022, Microbiology spectrum.

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

A. Oliver, L. Leibovici, D. Paterson, 2022, Infectious Disease and Therapy.

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study.

A. Oliver, L. Leibovici, D. Paterson, 2019, International journal of antimicrobial agents.

External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance.

E. Pérez-Nadales, R. Bonomo, Y. Carmeli, 2019, International journal of antimicrobial agents.

Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)

C. Tebé, P. Martín-Dávila, J. Rodríguez-Baño, 2017, BMJ Open.

The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection

P. Viale, M. Giannella, R. Pascale, 2019, Expert review of anti-infective therapy.

Ceftazidime-avibactam in the Treatment of Infections Caused by KPC-producing K. pneumoniae: factors associated with clinical efficacy in a single-center cohort.

E. Pérez-Nadales, L. Martínez-Martínez, J. Torre-Cisneros, 2020, International journal of antimicrobial agents.

Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated with Antithymocyte Globulin: A Randomized Clinical Trial.

P. Muñoz, J. Yuste, D. Redondo-Pachón, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project)

E. Pérez-Nadales, E. Seminari, P. Martín-Dávila, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.

A. Oliver, L. Leibovici, D. Paterson, 2021, The Journal of antimicrobial chemotherapy.

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

E. Pérez-Nadales, J. Rodríguez-Baño, J. Torre-Cisneros, 2017, Antimicrobial Agents and Chemotherapy.

Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study

A. Oliver, D. Yahav, E. Gonzalez-Barbera, 2022, Infection.

Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae

J. Rodríguez-Baño, L. Martínez-Martínez, J. Torre-Cisneros, 2020, Antimicrobial Agents and Chemotherapy.

Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales. A randomized, controlled trial.

J. Pachón, J. Rodríguez-Baño, J. Cisneros, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing Klebsiella pneumoniae (KAPEDIS)

E. Pérez-Nadales, L. Martínez-Martínez, J. Torre-Cisneros, 2022, BMJ Open.

Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

E. Pérez-Nadales, J. Rodríguez-Baño, L. Martínez-Martínez, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Nikolaos A. Triarides, H. Goossens, A. Georgescu, 2023, EClinicalMedicine.

Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients

E. Pérez-Nadales, J. Rodríguez-Baño, L. Martínez-Martínez, 2022, Microbiology spectrum.

Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis

M. Recio, E. Pérez-Nadales, J. Cisneros, 2021, Antibiotics.

Impact of a Carbapenem Stewardship Programme on the Incidence of Carbapenem-Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis

E. Pérez-Nadales, J. Cisneros, L. Martínez-Martínez, 2021 .

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature.

M. Recio, E. Pérez-Nadales, L. Martínez-Martínez, 2019, Journal of global antimicrobial resistance.

Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: the impact of inappropriate empirical treatment.

E. Pérez-Nadales, J. Rodríguez-Baño, L. Martínez-Martínez, 2019, The Journal of infection.

Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain

J. Cisneros, J. Torre-Cisneros, L. Tallón-Aguilar, 2022, BMJ Open.

Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study.

A. Oliver, L. Leibovici, D. Paterson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study

J. Torre-Cisneros, A. B. Pérez, S. Cantisán, 2023, Frontiers in Immunology.

Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).

B. Carevic, G. Dragovac, M. D. de Kraker, 2024, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.